FindTrial
Sign In

Argon Plasma Coagulation versus Endoscopic Submucosal Dissection to Treat Gastric Adenoma

Argon Plasma Coagulation versus Endoscopic Submucosal Dissection to Treat Gastric Adenoma: a systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009840
Enrollment
1000
Registered
2024-10-11
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - All studies comparing conventional ESD with APC as a treatment method for gastric adenoma were considered eligible. - Based on the PICO framework for meta-analyses (a) Population: patients with gastric adenoma (b) Intervention: Argon Plasma Coagulation or Endoscopic Submucosal Dissection (c) Comparator: Argon Plasma Coagulation or Endoscopic Submucosal Dissection (d) Outcomes: local recurrence rate, complication rate, procedure time, duration of hospital stay

Exclusion criteria

Exclusion criteria: - single-arm study without a control (conventional ESD) group - Conference abstracts - Reviews - Editorials - Opinions - Letters - Case report or series

Design outcomes

Primary

MeasureTime frame
local recurrence rates—

Secondary

MeasureTime frame
complication—

Countries

Korea, Republic of

Contacts

Public ContactSang Pyo Lee

Hanyang University Seoul Hospital

ultra_pyo@hanmail.net+82-2-2290-8343

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026